Bone Mineral Density Enhancement Function Test: Protocols, Methods and Evaluation Criteria

The Bone Mineral Density (BMD) Enhancement Function Test is a standardized biological evaluation used to verify whether health foods, dietary supplements, and functional ingredients can effectively improve bone density and overall bone quality. Conducted in accredited third-party laboratories in accordance with national health food function test and evaluation guidelines, the test combines calcium-deficient animal models, dual-energy X-ray absorptiometry (DXA), bone calcium quantification, and biomechanical analysis. This article explains the test principle, sample types, testing items, experimental methods, judgment criteria, and typical applications in product registration and claim substantiation.

Technical Overview

The Bone Mineral Density Enhancement Function Test is a recognized biological evaluation method designed to determine whether a test substance can measurably increase bone mineral density (BMD) and improve bone quality. It is most commonly applied to health foods and functional food products that claim a bone-health function, and it forms a core part of the technical dossier required for product registration or filing under national health food function evaluation systems.

The test is built on the principle of experimentally induced bone mineral loss. Young growing animals are fed a calcium-restricted purified diet, which depresses skeletal mineralization. Test substances are administered orally over an extended period, and the skeletal response is assessed by comparing bone mineral density, bone calcium content, bone biomechanical strength, and bone microstructure against both a normal-calcium control group and a low-calcium model control group. A calcium carbonate control group, matched to the calcium content of the test substance, is included to distinguish a simple calcium supplementation effect from additional functional effects of the sample.

Evaluation endpoints follow the requirements of national health food function test and evaluation methods, with analytical determinations referenced to applicable GB food safety and nutrition testing standards. Testing laboratories typically operate under an ISO/IEC 17025 quality management system, ensuring the technical validity and traceability of all measurements.

Testing Samples

Health Foods and Dietary Supplements

Finished products in conventional dosage forms, including tablets, hard and soft capsules, granules, powders, oral liquids, and functional beverages. Samples should be representative of the commercial formulation, with the recommended daily human intake and calcium content per dose clearly documented.

Functional Ingredients and Raw Materials

• Calcium salts, including calcium carbonate, calcium citrate, calcium gluconate, and amino acid chelated calcium
• Vitamin D3, vitamin K2 (MK-7), and vitamin C as co-active micronutrients
• Collagen peptides, milk basic protein, and casein phosphopeptides (CPP)
• Soy isoflavones and other phytoestrogen-rich botanical extracts
• Chondroitin sulfate, shark cartilage extracts, and bone-derived mineral complexes
• Novel food ingredients and compound formulas intended for bone-health claims

Sample Submission Requirements

Applicants should provide sufficient sample quantity to cover the full dosing period for all animal groups, along with product composition data, calcium and phosphorus content, recommended dosage, physical and chemical properties, shelf-life information, and batch production records. Samples must be stable under the storage conditions declared for the study.

Testing Items

The test battery evaluates both functional efficacy and general safety observations:

• Body weight, food intake, and food utilization rate throughout the dosing period
• Apparent calcium absorption rate determined by metabolic balance study
• Bone mineral density of the femur, lumbar vertebrae, and whole body by DXA
• Bone calcium content and, where relevant, bone phosphorus and magnesium content
• Bone biomechanical parameters, including femur maximum load, bending strength, stiffness, and energy absorption in three-point bending
• Bone histomorphometry, including trabecular area ratio, trabecular number, thickness, and separation
• Serum and urine biochemistry, such as calcium, phosphorus, alkaline phosphatase (ALP), osteocalcin, and bone resorption markers
• Organ weights and gross pathological observation to confirm the absence of adverse effects

Testing Methods

Animal Experiment Design

Weanling Sprague-Dawley rats (or mice) of a single sex are randomly assigned to experimental groups after an acclimation period. A typical design includes a normal-calcium control group, a low-calcium model control group, three dose levels of the test sample, and a calcium carbonate positive control group. All animals except the normal control receive a low-calcium purified diet, while the test sample is administered daily by oral gavage. Dose levels are set as multiples of the recommended human intake, and the dosing period generally extends over 8 to 12 weeks to allow measurable skeletal responses.

Bone Mineral Density Measurement

Bone mineral density is measured by dual-energy X-ray absorptiometry (DXA), the reference technique for bone mass quantification. Excised femurs and lumbar vertebrae, or whole-body scans, are analyzed to determine areal BMD (g/cm²). Quantitative computed tomography (QCT) may be used as a complementary method when volumetric BMD data are required.

Bone Calcium Determination

Bone samples are dried, ashed at high temperature, and acid digested. Calcium concentration is quantified by flame atomic absorption spectrometry or inductively coupled plasma optical emission spectrometry (ICP-OES), following nationally recognized food and biological sample analysis methods such as GB 5009.92. Results are expressed as bone calcium content per unit of dry or ash weight.

Calcium Absorption and Metabolic Balance Study

A metabolic cage balance trial is performed over a defined collection window. Calcium intake from diet and test sample, together with fecal and urinary calcium excretion, is measured to calculate the apparent absorption rate. This distinguishes improved calcium bioavailability from effects on bone metabolism.

Bone Biomechanics and Histology

Femoral diaphysis strength is evaluated by three-point bending, and vertebral compressive strength may be assessed in parallel. For histological examination, bones are fixed, sectioned, and stained, and static histomorphometric parameters of trabecular bone are quantified by image analysis.

Data Processing and Judgment Criteria

Results are analyzed statistically, typically by analysis of variance with appropriate post-hoc comparisons. A positive determination generally requires that bone mineral density and/or bone calcium content of the test groups be significantly higher than the low-calcium model control group, without adverse effects on body weight, food intake, or general health. Comparison with the calcium carbonate control group is used to characterize whether the observed effect is attributable solely to calcium supplementation or to additional functional components. Where toxicity screening is bundled with the study, the GB 15193 series of food safety toxicological procedures may be integrated into the overall evaluation.

Human Trial Option

For eligible products, a human clinical trial may be conducted as supporting or primary evidence. Such trials follow a randomized, double-blind, placebo-controlled design in populations at risk of bone mineral loss. Endpoints include DXA-measured BMD of the lumbar spine and proximal femur, together with bone turnover biomarkers, over a study period typically extending 12 months or longer, in compliance with applicable ethical review and clinical research quality requirements.

Applications

• Technical dossiers for the registration or filing of health foods claiming a bone density enhancement function
• Scientific substantiation for structure/function claims related to bone health in domestic and export markets
• Research and development screening of calcium sources, absorption enhancers, and compound formulations
• Comparative efficacy studies between different dosage forms and ingredient combinations
• Quality and efficacy verification for nutritionally fortified foods formulated under fortification standards such as GB 14880
• Academic research on nutritional interventions for bone metabolism and osteoporosis prevention

FAQ

What standards govern the test? The core protocol follows national health food function test and evaluation methods, with calcium determinations referenced to GB analytical standards and laboratory quality systems conforming to ISO/IEC 17025. Toxicology screening, when required, follows the GB 15193 series.

How long does the animal test take? Including acclimation, dosing of 8 to 12 weeks, and subsequent laboratory analysis, the complete animal study typically requires three to four months. Human trials require a minimum of 12 months to capture meaningful BMD changes.

What sample quantity should be submitted? Sufficient material must be provided to dose all groups, including three dose levels and controls, for the entire study period. As a practical guide, several hundred dosage units or several kilograms of bulk product are recommended.

What constitutes a positive test result? A positive result requires that bone mineral density or bone calcium content of the test groups be significantly higher than the low-calcium model control, with no adverse effects on growth or general health, and with the role of calcium content itself clarified through the calcium carbonate reference group.

Why is a calcium control group included? The calcium carbonate group, matched to the calcium intake delivered by the high-dose sample group, allows evaluators to determine whether the test substance offers benefits beyond those achievable by elemental calcium alone.

Can the test be combined with other studies? Yes. Bone density testing is frequently performed alongside calcium absorption studies, toxicological safety assessments, and stability testing to build a complete registration dossier.